← All trials
NCT06545617
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2025
- Primary completion
- Mar 10, 2026
- Completion date
- Jan 31, 2028
- First posted
- Aug 9, 2024
- Last posted
- Oct 16, 2024
- Enrollment
- 170
- Arms / groups
- 3 / —
- Source
- AACT · ctgov ingestion
Sponsors
- BiotheraLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.